Dezhan Healthcare Company Limited (SHE:000813)
China · Delayed Price · Currency is CNY 4.310
+0.120 (2.86%)
Sep 26, 2025, 3:04 PM CST
Dezhan Healthcare Company Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -73.49 | -20.41 | 83.31 | -46.95 | -57.58 | 284.54 | Upgrade |
Depreciation & Amortization | 87.06 | 83.99 | 83.67 | 94.2 | 84.52 | 68.57 | Upgrade |
Other Amortization | 9.05 | 6.28 | 5.19 | 6.96 | 2.54 | 2.8 | Upgrade |
Loss (Gain) From Sale of Assets | 0.02 | 0.02 | 0.03 | -0.33 | -0.02 | -0 | Upgrade |
Asset Writedown & Restructuring Costs | 0.78 | 1.56 | 7.23 | 41.98 | 14.51 | 2.49 | Upgrade |
Loss (Gain) From Sale of Investments | 22.25 | 19.87 | -80.31 | -19.19 | -32.09 | -95.45 | Upgrade |
Provision & Write-off of Bad Debts | -0.87 | 5.84 | 4.82 | -0.05 | 1.04 | 9.28 | Upgrade |
Other Operating Activities | -13.19 | -11.13 | -5.27 | 5 | 138.44 | -20.05 | Upgrade |
Change in Accounts Receivable | -17.92 | -97.09 | 168.74 | 9.28 | 19.89 | 473.8 | Upgrade |
Change in Inventory | -3.27 | 9.88 | 130.78 | -22.26 | 35.58 | 20.06 | Upgrade |
Change in Accounts Payable | 24.76 | 5.79 | -282.65 | 86.07 | -184.93 | 67.91 | Upgrade |
Operating Cash Flow | 23.5 | -14.59 | 127.87 | 161.72 | 42.41 | 827.54 | Upgrade |
Operating Cash Flow Growth | -65.01% | - | -20.93% | 281.32% | -94.88% | -46.91% | Upgrade |
Capital Expenditures | -227.02 | -166.55 | -159.73 | -67.56 | -126.92 | -110.28 | Upgrade |
Sale of Property, Plant & Equipment | 0.25 | 0.09 | 0.01 | 1.48 | 0.06 | 0.02 | Upgrade |
Cash Acquisitions | - | - | -10.36 | - | - | -276.93 | Upgrade |
Divestitures | - | - | -51.9 | - | - | - | Upgrade |
Investment in Securities | -47.91 | -12.91 | 400 | 1,018 | 185.58 | -261.5 | Upgrade |
Other Investing Activities | 0 | - | - | 56.67 | 37.76 | 104.15 | Upgrade |
Investing Cash Flow | -274.68 | -179.38 | 178.02 | 1,009 | 96.47 | -544.54 | Upgrade |
Short-Term Debt Issued | - | - | 4.09 | - | 1.2 | 9.8 | Upgrade |
Total Debt Issued | 114.8 | - | 4.09 | - | 1.2 | 9.8 | Upgrade |
Short-Term Debt Repaid | - | -0.47 | -1.93 | - | -1.2 | -5.63 | Upgrade |
Long-Term Debt Repaid | - | -4.26 | -2.39 | -3.2 | -7.12 | - | Upgrade |
Total Debt Repaid | -8.01 | -4.73 | -4.32 | -3.2 | -8.32 | -5.63 | Upgrade |
Net Debt Issued (Repaid) | 106.79 | -4.73 | -0.23 | -3.2 | -7.12 | 4.17 | Upgrade |
Issuance of Common Stock | 4 | - | - | - | - | 39.98 | Upgrade |
Repurchase of Common Stock | -180.39 | -73.28 | -159.85 | -11.83 | -10.98 | - | Upgrade |
Common Dividends Paid | -0.35 | -0.08 | -0.03 | - | -470.29 | -0.03 | Upgrade |
Other Financing Activities | - | - | - | -33.1 | - | 9.91 | Upgrade |
Financing Cash Flow | -69.95 | -78.09 | -160.11 | -48.12 | -488.39 | 54.03 | Upgrade |
Foreign Exchange Rate Adjustments | 0 | 0 | 0 | 0 | -0.22 | -0.39 | Upgrade |
Net Cash Flow | -321.13 | -272.05 | 145.79 | 1,123 | -349.74 | 336.64 | Upgrade |
Free Cash Flow | -203.52 | -181.14 | -31.86 | 94.16 | -84.51 | 717.25 | Upgrade |
Free Cash Flow Growth | - | - | - | - | - | -51.98% | Upgrade |
Free Cash Flow Margin | -52.93% | -38.83% | -6.40% | 16.50% | -11.51% | 74.49% | Upgrade |
Free Cash Flow Per Share | -0.10 | -0.08 | -0.01 | 0.04 | -0.04 | 0.32 | Upgrade |
Cash Interest Paid | 0.09 | 0.09 | 0.11 | 0.12 | 0.15 | 0.13 | Upgrade |
Cash Income Tax Paid | 58.28 | 64.16 | 76.64 | 82.18 | 118.72 | 209.96 | Upgrade |
Levered Free Cash Flow | -240.4 | -193.47 | -128.19 | 137.18 | 37.09 | 373.92 | Upgrade |
Unlevered Free Cash Flow | -239.93 | -193.24 | -127.96 | 137.62 | 37.5 | 374.04 | Upgrade |
Change in Working Capital | -8.11 | -100.62 | 29.19 | 80.1 | -108.95 | 575.35 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.